Avience Biomedicals Ltd. is a medical consumable company, which engages in dealing in and manufacturing of Vitro-Diagnostic products and medical devices. It also engages in the production of essential diagnostic kits like Viral Transport Media, Covid, HIV, HBs AG, Malaria, Dengue, and others aimed at aiding medical institutions. The company was founded on December 23, 2019 and is headquartered in New Delhi, India.
Sector:
Health Technology
Industry:
Medical Specialties
Employees:
N/A
Frequently Asked Questions
What is Market Cap of Avience Biomedicals Ltd.?
Market cap, also known as market capitalization, is the total market value of a company. It's calculated by multiplying the current market price by the total number of shares outstanding. Avience Biomedicals Ltd. market cap is 2.39B.
What is the 52-week high for Avience Biomedicals Ltd.?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Avience Biomedicals Ltd. 52 week high is 414.95 as of June 27, 2026.
What is the 52-week low for Avience Biomedicals Ltd.?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Avience Biomedicals Ltd. 52 week low is 395.20 as of June 27, 2026.
What is Avience Biomedicals Ltd. stock price today?
Avience Biomedicals Ltd. stock price today is 414.95.
What is the 50-day moving average of Avience Biomedicals Ltd.?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It's calculated by averaging the closing stock price over the previous 50 trading days. Avience Biomedicals Ltd. 50-day moving average is 414.95.